Pac Premier
Giving Guide
You are here:  Home  >  Biotech  >  Current Article

Amgen’s first quarter earnings beat analyst estimates

By   /   Thursday, April 30th, 2020  /   Comments Off on Amgen’s first quarter earnings beat analyst estimates

    Print       Email
Thousand Oaks-based biotech giant Amgen's revenues rose 11 percent in the first quarter to $6.2 billion but earnings per share dipped 3 percent to $3.07 apiece.  Sales volumes increased, offset by lower overall prices, Amgen said in filings with regulators April 30. Net income fell 8 percent compared to the previous first quarter to $1.83…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Limoneira, Calavo both report earnings growth as produce industry continues recovery

Read More →